SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?


To: Graham Dellaire who wrote (660)5/5/1998 10:27:00 AM
From: OtherChap  Respond to of 2135
 
Well, since possibly having the cure for cancer doesnt seem to be helping this stock today, did anyone hear the rumor that ENMD is going to open a web site and start selling cheesy 70's records that nobody wants over the internet? That should be good for another 60 points or so!




To: Graham Dellaire who wrote (660)5/5/1998 10:52:00 AM
From: whitephosphorus  Read Replies (1) | Respond to of 2135
 
Slightly off topic.....Alfacell
This company has a market cap of 75mm vs 600mm for ENMD and is in Phase 3 for pancreatic cancer and phase 2 for others. The SI thread on this company is amusing at times, but I wonder if anyone here has an opinion?

From ACEL thread
To: John Jenco (1283 )
From: leighton stallones Monday, May 4 1998 6:49PM ET
Reply # of 1295

Yes endostatin appears exciting BUT,this drug is where Onconase
was in early 1988 ,a year before human phase 1 trials. We heard
fabulous mouse stories then too abt Pannon. Bristol has a very large
advertising budget and the NY Times is very attentive when they are
promoting an effort as we saw with Taxol which as you know turned
out much less important than the hype. Also the NCI after $30 billion
spent since 1972 and little to show for it is desperate for favorable
publicity. We{they} have no idea yet the physiological effects in
humans on the endostatin drugs. They may or may not be tolerated and
at best 7-8 years away.
I believe the only short selling was by dealers in their normal
trading habits selling stk on a rise. As the stk breaks over 4 1/2 they
will be in covering. I dont believe the P.P. people were selling. Its too
early and amateur. Conversely I believe these are Rosenwald followers
buying the stock

| Previous | Next | Respond | View 2 replies to this message